BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 34581850)

  • 21. Clinical Outcomes of HPV-associated and Unassociated Endocervical Adenocarcinomas Categorized by the International Endocervical Adenocarcinoma Criteria and Classification (IECC).
    Stolnicu S; Hoang L; Chiu D; Hanko-Bauer O; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Oliva E; Park KJ; Abu-Rustum NR; Soslow RA
    Am J Surg Pathol; 2019 Apr; 43(4):466-474. PubMed ID: 30720532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. International Endocervical Adenocarcinoma Criteria and Classification (IECC): correlation with adverse clinicopathological features and patient outcome.
    Hodgson A; Olkhov-Mitsel E; Howitt BE; Nucci MR; Parra-Herran C
    J Clin Pathol; 2019 May; 72(5):347-353. PubMed ID: 30679193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastric-type adenocarcinoma in situ of uterine cervix: cytological and histopathological features of two cases.
    Yuan CT; Lin MC; Kuo KT; Wang TH; Mao TL
    Virchows Arch; 2016 Sep; 469(3):351-6. PubMed ID: 27334141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
    Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
    Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PAX8 expression in uterine adenocarcinomas and mesonephric proliferations.
    Yemelyanova A; Gown AM; Wu LS; Holmes BJ; Ronnett BM; Vang R
    Int J Gynecol Pathol; 2014 Sep; 33(5):492-9. PubMed ID: 25083965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcriptome profiling of gastric-type endocervical adenocarcinomas identifies key signaling pathways for tumor progression.
    Vasseur D; Lopez J; Croce S; Tondeur G; Bonin L; Descotes F; Golfier F; Devouassoux-Shisheboran M
    Gynecol Oncol; 2020 Jun; 157(3):775-782. PubMed ID: 32317172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of the Utility of PAX8 Immunohistochemical Stain in Diagnosing Endocervical Glandular Lesions.
    Liang L; Zheng W; Liu J; Liang SX
    Arch Pathol Lab Med; 2016 Feb; 140(2):148-52. PubMed ID: 26910219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synchronous and metachronous endocervical and ovarian neoplasms: evidence supporting interpretation of the ovarian neoplasms as metastatic endocervical adenocarcinomas simulating primary ovarian surface epithelial neoplasms.
    Elishaev E; Gilks CB; Miller D; Srodon M; Kurman RJ; Ronnett BM
    Am J Surg Pathol; 2005 Mar; 29(3):281-94. PubMed ID: 15725796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2.
    McCluggage WG; Shah R; Connolly LE; McBride HA
    Int J Gynecol Pathol; 2008 Jan; 27(1):92-100. PubMed ID: 18156982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endocervical glandular lesions exhibiting gastric differentiation: an emerging spectrum of benign, premalignant, and malignant lesions.
    Mikami Y; McCluggage WG
    Adv Anat Pathol; 2013 Jul; 20(4):227-37. PubMed ID: 23752085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p16 Immunoreactivity in unusual types of cervical adenocarcinoma does not reflect human papillomavirus infection.
    Houghton O; Jamison J; Wilson R; Carson J; McCluggage WG
    Histopathology; 2010 Sep; 57(3):342-50. PubMed ID: 20727021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A panel of 3 markers including p16, ProExC, or HPV ISH is optimal for distinguishing between primary endometrial and endocervical adenocarcinomas.
    Kong CS; Beck AH; Longacre TA
    Am J Surg Pathol; 2010 Jul; 34(7):915-26. PubMed ID: 20534993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cervical Glandular Neoplasia: Classification and Staging.
    Turashvili G; Park KJ
    Surg Pathol Clin; 2019 Jun; 12(2):281-313. PubMed ID: 31097105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stromal invasion pattern identifies patients at lowest risk of lymph node metastasis in HPV-associated endocervical adenocarcinomas, but is irrelevant in adenocarcinomas unassociated with HPV.
    Stolnicu S; Barsan I; Hoang L; Patel P; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Oliva E; Park KJ; Abu-Rustum NR; Pike MC; Soslow RA
    Gynecol Oncol; 2018 Jul; 150(1):56-60. PubMed ID: 29859673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential patterns of PAX8, p16, and ER immunostains in mesonephric lesions and adenocarcinomas of the cervix.
    Goyal A; Yang B
    Int J Gynecol Pathol; 2014 Nov; 33(6):613-9. PubMed ID: 25272301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endocervical glandular neoplasia associated with lobular endocervical glandular hyperplasia is HPV-independent and correlates with carbonic anhydrase-IX expression: a Gynaecological Oncology Group Study.
    Liao SY; Rodgers WH; Kauderer J; Darcy KM; Carter R; Susumu N; Nagao S; Walker JL; Hatae M; Stanbridge EJ
    Br J Cancer; 2013 Feb; 108(3):613-20. PubMed ID: 23299542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endocervical adenocarcinomas with ovarian metastases: analysis of 29 cases with emphasis on minimally invasive cervical tumors and the ability of the metastases to simulate primary ovarian neoplasms.
    Ronnett BM; Yemelyanova AV; Vang R; Gilks CB; Miller D; Gravitt PE; Kurman RJ
    Am J Surg Pathol; 2008 Dec; 32(12):1835-53. PubMed ID: 18813124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas.
    Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM
    Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mesonephric adenocarcinomas of the uterine cervix and corpus: HPV-negative neoplasms that are commonly PAX8, CA125, and HMGA2 positive and that may be immunoreactive with TTF1 and hepatocyte nuclear factor 1-β.
    Kenny SL; McBride HA; Jamison J; McCluggage WG
    Am J Surg Pathol; 2012 Jun; 36(6):799-807. PubMed ID: 22456609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor Typing of Endocervical Adenocarcinoma: Contemporary Review and Recommendations From the International Society of Gynecological Pathologists.
    Stolnicu S; Park KJ; Kiyokawa T; Oliva E; McCluggage WG; Soslow RA
    Int J Gynecol Pathol; 2021 Mar; 40(Suppl 1):S75-S91. PubMed ID: 33570865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.